Answers are grounded in this paper and cite their sources.
safety profiling becomes increasingly critical. Comprehensive evaluation in relevant CNS models will be essential to minimize risk and improve translational predictability for developing safe and effective ASO treatments for neurological diseases.
No takes yet. Share an insight, caveat, or question.
Zanjko et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: